Coronary Angiography THerapeutic Virtual Reality

• Status: Unknown status
• Trial end date: 2018-06-30
• Target enrollment: 0
• Participant gender: All

Summary

The CATH-VR study will investigate the effect of virtual reality (VR) on patient pain, anxiety, and radial artery vasospasm during coronary angiography. Our hypothesis is that the use of VR will decrease patient anxiety and pain via validated scoring systems, as well as show a low rate of vasospasm of the radial artery. In addition, we hypothesize that the amount of opioid and benzodiazepine medications utilized for procedural sedation will be lower in the intervention arm. VR has gained recent attraction as an alternative or adjunctive treatment option for pain, but its effect on reducing procedural sedation has not been studied. We propose a single center, randomized control pilot study to further investigate. The patient population will include adults older than 18 years who present for outpatient diagnostic coronary angiography.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of California, Los Angeles
• Collaborators: AppliedVR Inc.; AppliedVR, Inc.
• Treatments: Fentanyl; Midazolam

Criteria

Inclusion Criteria:

• Age greater than or equal to 18 years undergoing diagnostic coronary angiogram

Exclusion Criteria:

• Claustrophobia

• Seizure disorder

• Motion sickness

• Stroke within the past year

• Dementia

• Nausea

• Isolation status for infection control

• Do not wish to participate.